A phase 1b expansion study of TAS‐102 with oxaliplatin for refractory metastatic colorectal cancer-Reference-Cited by-同舟云学术

A phase 1b expansion study of TAS‐102 with oxaliplatin for refractory metastatic colorectal cancer

Published:2020-12-22 Issue:9 Volume:127 Page:1417-1424
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Cecchini Michael¹^ORCID,Kortmansky Jeremy S.¹,Cui Can²,Wei Wei²,Thumar Jaykumar Ranchobdhai¹,Uboha Nataliya V.³,Hafez Navid¹,Lacy Jill¹,Fischbach Neal A.¹,Sabbath Kert D.¹,Gomez Christina M.¹,Sporn Jonathan Reed¹,Stein Stacey¹,Hochster Howard S.⁴

Affiliation:

1. Department of Internal Medicine (Medical Oncology) Yale University School of Medicine New Haven Connecticut

2. Department of Biostatistics Yale School of Public Health New Haven Connecticut

3. Hematology‐Oncology Section Department of Medicine University of Wisconsin Carbone Cancer Center Madison Wisconsin

4. Rutgers Cancer Institute of New Jersey New Brunswick New Jersey

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.33379

Reference22 articles.

1. Cancer statistics, 2020

2. World Health Organization International Agency for Research on Cancer.GLOBOCAN 2018: estimated cancer incidence mortality and prevalence worldwide in 2018. Published February2019. Accessed April 18 2020.http://gco.iarc.fr/today/data/factsheets/cancers/10_

3. National Comprehensive Cancer Network.NCCN clinical practice guidelines in oncology for colon cancer. Version 3. Accessed December 7 2020.https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf

4. Can Chemotherapy Be Discontinued in Unresectable Metastatic Colorectal Cancer? The GERCOR OPTIMOX2 Study

5. Improved time to treatment failure with an intermittent oxaliplatin strategy: results of CONcePT

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Trifluridine/Tipiracil-Containing Combinations in Colorectal Cancer and Other Advanced Solid Tumors: A Systematic Review;The Oncologist;2024-02-16

2. A novel oxaliplatin-resistant gene signatures predicting survival of patients in colorectal cancer;BIOCELL;2024

3. Effects and mechanisms of trifluridine alone or in combination with cryptotanshinone in inhibiting malignant biological behavior of gastric cancer;Cell Cycle;2023-06-04

4. Research progress of traditional Chinese medicine as sensitizer in reversing chemoresistance of colorectal cancer;Frontiers in Oncology;2023-03-13

5. The efficacy and safety of trifluridine/tipiracil plus bevacizumab compared with trifluridine/tipiracil monotherapy for metastatic colorectal cancer: A meta-analysis;Digital Medicine;2022